Trial Profile
Monotherapy in Africa: Evaluation of New Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Atazanavir/ritonavir; Lopinavir/ritonavir; Nucleoside reverse transcriptase inhibitors; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MANET
- 01 Jun 2017 Status changed from recruiting to completed.
- 18 Jul 2014 New trial record